Literature DB >> 2203800

Modulation of HLA-DR expression in epithelial cells by interleukin 1 and estradiol-17 beta.

S S Tabibzadeh1, A Sivarajah, D Carpenter, B M Ohlsson-Wilhelm, P G Satyaswaroop.   

Abstract

Both ultrapure human interleukin-1 (IL-1) and Escherichia coli derived recombinant IL-1 alpha and beta consistently induced the expression of major histocompatibility class II (HLA-DR) molecules in a human endometrial and a breast carcinoma cell line. [35S]Methionine incorporation into IL-1 induced, immunoprecipitable HLA-DR molecules demonstrated de novo synthesis of both light and heavy chains of the HLA-DR molecules. Lipopolysaccharide, recombinant interleukin-2 and recombinant interleukin-6 failed to induce HLA-DR expression in these epithelial cells. In contrast to the dramatic effect on HLA-DR expression, IL-1 had no effect on the epithelial cell proliferation. Pretreatment of T47D cells with estradiol-17 beta significantly decreased the IL-1 induced HLA-DR expression, and pretreatment of IL-1 with an IL-1 specific antibody, neutralized IL-1 action. These studies demonstrate that a cytokine (IL-1) and a sex steroid hormone estradiol-17 beta can interact to regulate the expression of HLA-DR molecules in epithelial cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2203800     DOI: 10.1210/jcem-71-3-740

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

Review 1.  Understanding sex biases in immunity: effects of estrogen on the differentiation and function of antigen-presenting cells.

Authors:  Greg Nalbandian; Susan Kovats
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 2.  Type 1 diabetes mellitus and multiple sclerosis: common etiological features.

Authors:  Adam E Handel; Lahiru Handunnetthi; George C Ebers; Sreeram V Ramagopalan
Journal:  Nat Rev Endocrinol       Date:  2009-11-03       Impact factor: 43.330

3.  Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy.

Authors:  Jacques Thibodeau; Marie-Claude Bourgeois-Daigneault; Réjean Lapointe
Journal:  Oncoimmunology       Date:  2012-09-01       Impact factor: 8.110

4.  XomAnnotate: Analysis of Heterogeneous and Complex Exome- A Step towards Translational Medicine.

Authors:  Asoke K Talukder; Shashidhar Ravishankar; Krittika Sasmal; Santhosh Gandham; Jyothsna Prabhukumar; Prahalad H Achutharao; Debmalya Barh; Francesco Blasi
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

5.  Balance between Estrogens and Proinflammatory Cytokines Regulates Chemokine Production Involved in Thymic Germinal Center Formation.

Authors:  Nadine Dragin; Patrice Nancy; José Villegas; Régine Roussin; Rozen Le Panse; Sonia Berrih-Aknin
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

6.  Tumor-intrinsic PIK3CA represses tumor immunogenecity in a model of pancreatic cancer.

Authors:  Nithya Sivaram; Patrick A McLaughlin; Han V Han; Oleksi Petrenko; Ya-Ping Jiang; Lisa M Ballou; Kien Pham; Chen Liu; Adrianus Wm van der Velden; Richard Z Lin
Journal:  J Clin Invest       Date:  2019-05-21       Impact factor: 19.456

7.  The long non-coding RNA GHSROS facilitates breast cancer cell migration and orthotopic xenograft tumour growth.

Authors:  Patrick B Thomas; Inge Seim; Penny L Jeffery; Manuel D Gahete; Michelle Maugham; Gabrielle J Crisp; Andrew Stacey; Esha T Shah; Carina Walpole; Eliza J Whiteside; Colleen C Nelson; Adrian C Herington; Raúl M Luque; Rakesh N Veedu; Lisa K Chopin
Journal:  Int J Oncol       Date:  2019-10-04       Impact factor: 5.650

8.  Activation of ERα signaling differentially modulates IFN-γ induced HLA-class II expression in breast cancer cells.

Authors:  Ahmed A Mostafa; Dianne Codner; Kensuke Hirasawa; Yumiko Komatsu; Matthew N Young; Viktor Steimle; Sheila Drover
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

9.  Measurements of heterotypic associations between cluster of differentiation CD74 and CD44 in human breast cancer-derived cells.

Authors:  Hussain Al Ssadh; Patrick S Spencer; Waleed Alabdulmenaim; Rana Alghamdi; Inamul Hasan Madar; Jose M Miranda-Sayago; Nelson Fernández
Journal:  Oncotarget       Date:  2017-09-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.